Search

everythinglearnresearchcommunity

for

Search:↓

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Systemic corticosteroids don't prevent severe alopecia areata from spreading or relapsing.

A woman developed lupus after taking hydroxyurea for two years.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Surgical excision is the best treatment for SCC.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

Enhancing Tregs can protect against alopecia areata.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.